Wednesday, 20 February 2019
Latest news
Main » New England Research & Management Inc. Raises Stake in Celgene Co. (CELG)

New England Research & Management Inc. Raises Stake in Celgene Co. (CELG)

11 February 2018

The stock decreased 0.33% or $0.07 during the last trading session, reaching $21.23. MARIO ERNEST sold $2.42M worth of stock or 18,506 shares. Alibaba Group Holding Limited (NYSE:BABA) has risen 57.33% since February 10, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Braun Stacey Associates Inc increased its stake in Celgene Corp (CELG) by 51.58% based on its latest 2017Q3 regulatory filing with the SEC. Arrowstreet Capital Limited Partnership now owns 1,907,052 shares of the biopharmaceutical company's stock worth $247,669,000 after purchasing an additional 1,787,052 shares in the last quarter. The company's stock had a trading volume of 11,090,589 shares, compared to its average volume of 8,060,000. Vail Resorts, Inc. (NYSE:MTN) has risen 61.08% since February 10, 2017 and is uptrending. It has outperformed by 40.63% the S&P500.

Laurion Capital Management Lp, which manages about $4.98 billion and $22.63B US Long portfolio, upped its stake in General Electric Co (Call) (NYSE:GE) by 66,300 shares to 243,800 shares, valued at $5.90 million in 2017Q3, according to the filing. It also reduced its holding in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 10,000 shares in the quarter, leaving it with 2.00M shares, and cut its stake in Keryx Biopharmaceuticals Inc (NASDAQ:KERX).

Investors sentiment decreased to 1.17 in 2017 Q3. The company has a market capitalization of $70,720.00, a P/E ratio of 25.63, a P/E/G ratio of 0.65 and a beta of 1.49. It fall, as 44 investors sold CELG shares while 457 reduced holdings.

Zions Bancorporation raised its position in Celgene Co. The biopharmaceutical company reported $1.87 EPS for the quarter, topping the Zacks' consensus estimate of $1.78 by $0.09. Tokio Marine Asset Mgmt reported 2.08% of its portfolio in Celgene Corporation (NASDAQ:CELG). Sterling Cap Mngmt Limited Liability Corporation has invested 0% of its portfolio in Energy Transfer Equity, L.P. (NYSE:ETE).

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: which released: "Form 8-K CELGENE CORP /DE/ For: Feb 08" on February 08, 2018, also with their article: "Celgene Corporation to Webcast at Upcoming Investor Conferences" published on February 01, 2018, published: "Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc." on February 02, 2018. Da Davidson And Company reported 0.15% stake. Moreover, Piedmont Investment Advisors Ltd Liability has 0.52% invested in Celgene Corporation (NASDAQ:CELG) for 167,240 shares. Mitchell Capital Company reported 46,758 shares stake. Following the transaction, the insider now directly owns 178,904 shares of the company's stock, valued at $16,441,277.60. Hodges Cap invested in 1,507 shares.

In other news, insider Mark J. Alles acquired 3,260 shares of the company's stock in a transaction dated Thursday, February 8th. Philadelphia Company has 149,711 shares.

For the current quarter, 23 analysts are projecting a mean EPS of $1.95/share. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. Therefore 95% are positive.

Celgene (NASDAQ:CELG) was upgraded by research analysts at Vetr from a "buy" rating to a "strong-buy" rating in a research report issued to clients and investors on Wednesday, January 17th. Mizuho set a $128.00 target price on shares of Celgene and gave the stock a "buy" rating in a research note on Tuesday, December 26th. The stock of Celgene Corporation (NASDAQ:CELG) has "Buy" rating given on Thursday, January 7 by SunTrust. As per Friday, January 12, the company rating was maintained by Stifel Nicolaus. Robert W. Baird reissued a "buy" rating and set a $162.00 target price on shares of Celgene in a research note on Thursday, September 21st. The company has a consensus rating of "Buy" and an average target price of $130.35. The firm has "Buy" rating by Credit Suisse given on Thursday, July 6. The rating was maintained by RBC Capital Markets with "Buy" on Monday, August 7. The firm has "Buy" rating given on Friday, August 4 by Cowen & Co.

Since August 10, 2017, it had 0 insider buys, and 3 sales for $2.84 million activity. $248,498 worth of stock was sold by Curran Terrie on Monday, September 25.

Among 4 analysts covering Retrophin (NASDAQ:RTRX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 33% are positive. ConAgra Foods had 46 analyst reports since September 16, 2015 according to SRatingsIntel. 8,840 are held by Narwhal Capital. As per Thursday, April 7, the company rating was initiated by Sterne Agee CRT. The rating was maintained by Evercore with "Hold" on Thursday, August 3. The stock has "Buy" rating by Jefferies on Sunday, October 15. The rating was maintained by SunTrust with "Buy" on Friday, October 27. Cantor Fitzgerald reissued a "hold" rating and issued a $112.00 price objective on shares of Celgene in a report on Monday, October 30th. The rating was maintained by JP Morgan on Wednesday, April 6 with "Overweight". M Partners has "Buy" rating and $150 target. (NYSE:T) earned "Hold" rating by Independent Research on Tuesday, October 25. The firm has "Neutral" rating given on Monday, March 21 by Goldman Sachs. Its down 0.17, from 1.34 in 2017Q2. It increased, as 28 investors sold MTN shares while 103 reduced holdings. 55 funds opened positions while 133 raised stakes.

The Relative Volume of the company is 1.04 and Average Volume (3 months) is 6.96 million. Commonwealth Equity Ser accumulated 207,700 shares or 0.02% of the stock. TheStreet downgraded the shares of CAG in report on Thursday, September 24 to "Hold" rating. Regentatlantic Cap holds 0.26% or 20,706 shares in its portfolio. Sg Americas Securities Limited holds 0.03% or 105,798 shares. Plante Moran Finance Advisors holds 0.05% or 661 shares. Arizona State Retirement Sys, a Arizona-based fund reported 217,760 shares. Ls Invest Advsrs Ltd Liability Com reported 30,992 shares. Keybank Natl Association Oh has invested 0.71% in Celgene Corporation (NASDAQ:CELG). Vanguard Group stated it has 0.03% in Vail Resorts, Inc. 1,348 were accumulated by Tarbox Family Office Incorporated. 53,015 were accumulated by Wilkins Inv Counsel. Thompson Davis And Inc holds 0.01% or 125 shares. Midas Mngmt reported 1.42% in Accenture plc (NYSE:ACN).

Since August 28, 2017, it had 0 insider purchases, and 15 selling transactions for $9.01 million activity.